IMmune Proteomics to Predict neoAdjuvant Chemotherapy and immunoTherapy Response in Gastric Cancer
NCT06662110
·
clinicaltrials.gov ↗
RECRUITING
Status
206
Enrollment
OTHER
Sponsor class
Conditions
Gastric Cancer, Gastroesophageal Junction Cancer
Interventions
DIAGNOSTIC_TEST:
PSRscore
Sponsor
Shanghai Zhongshan Hospital